MW 252.22 Da, Purity >98%. Thymidine analog. Alternative to BrdU (5-Bromo-2'-deoxyuridine) (ab142567) for measuring de novo DNA synthesis during S-phase. Cytotoxic anti-metabolite. Used for probing short-term DNA synthesis in tissue culture and living organisms where prolonged cell survival is not required.
61135-33-9
> 98%
Solid
252.22 Da
C11H12N2O5
472172
Synthetic
Select an associated product type
MW 252.22 Da, Purity >98%. Thymidine analog. Alternative to BrdU (5-Bromo-2'-deoxyuridine) (ab142567) for measuring de novo DNA synthesis during S-phase. Cytotoxic anti-metabolite. Used for probing short-term DNA synthesis in tissue culture and living organisms where prolonged cell survival is not required.
61135-33-9
> 98%
Solid
252.22 Da
C11H12N2O5
472172
Synthetic
Soluble in water to 10 mM. Soluble in DMSO to 100 mM.
5-Ethynyl-2'-deoxyuridine
Thymidine analog. Alternative to BrdU (5-Bromo-2'-deoxyuridine) (ab142567) for measuring de novo DNA synthesis during S-phase. Cytotoxic anti-metabolite. Used for probing short-term DNA synthesis in tissue culture and living organisms where prolonged cell survival is not required.
C#CC1=CN(C(=O)NC1=O)C2CC(C(O2)CO)O
C#CC1=CN(C(=O)NC1=O)[C@H]2C[C@@H]([C@H](O2)CO)O
InChI=1S/C11H12N2O5/c1-2-6-4-13(11(17)12-10(6)16)9-3-7(15)8(5-14)18-9/h1,4,7-9,14-15H,3,5H2,(H,12,16,17)/t7-,8+,9+/m0/s1
CDEURGJCGCHYFH-DJLDLDEBSA-N
5-ethynyl-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione
Ambient - Can Ship with Ice
-20°C
Store under desiccating conditions, The product can be stored for up to 12 months
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
2D chemical structure image of ab146186, EdU, DNA synthesis monitoring probe
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com